A look at the weighted underlying holdings of the Fidelity MSCI Health Care Index ETF (Symbol: FHLC) shows an impressive 17.5% of holdings on a weighted basis have experienced insider buying within the past six months.
Vertex Pharmaceuticals, Inc. (Symbol: VRTX), which makes up 1.83% of the Fidelity MSCI Health Care Index ETF (Symbol: FHLC), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $52,278,754 worth of VRTX, making it the #16 largest holding. The table below details the recent insider buying activity observed at VRTX:
VRTX — last trade: $463.86 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 08/06/2025 | Reshma Kewalramani | CEO & President | 10,000 | $389.58 | $3,895,768 |
| 08/06/2025 | Bruce I. Sachs | Director | 5,000 | $389.68 | $1,948,416 |
And NeoGenomics Inc (Symbol: NEO), the #162 largest holding among components of the Fidelity MSCI Health Care Index ETF (Symbol: FHLC), shows 2 directors and officers as recently filing Form 4's indicating purchases. The ETF holds $728,252 worth of NEO, which represents approximately 0.03% of the ETF's total assets at last check. The recent insider buying activity observed at NEO is detailed in the table below:
NEO — last trade: $13.16 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 08/06/2025 | Jeffrey Scott Sherman | Chief Financial Officer | 20,000 | $5.62 | $112,322 |
| 08/06/2025 | Anthony P. Zook | Chief Executive Officer | 17,900 | $5.58 | $99,954 |
10 ETFs With Stocks That Insiders Are Buying »
Also see:
PER Historical Stock Prices
NTRA Insider Buying
IGIC Dividend Growth Rate
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
